JI 101

Known as: Angiogenesis Inhibitor JI-101, JI-101, JI101 cpd 
An orally active inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor beta (PDGFRb), and the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2015
01220112015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2015
Review
2015
The introduction of small-molecule tyrosine kinase VEGFR2 (vascular endothelial growth factor receptor) inhibitors has added… (More)
Is this relevant?
2012
2012
JI-101, chemically 1-[1-(2-amino-pyridin-4-ylmethyl)-1H-indol-4-yl]-3-(5-bromo-2-methoxy-phenyl)-urea hydrochloride, is a novel… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2012
2012
A highly sensitive, rapid assay method has been developed and validated for the estimation of JI-101 in human plasma and urine… (More)
Is this relevant?
2012
2012
A general practice in bioanalysis is that, whatever the biological matrix the analyte is being quantified in, the validation is… (More)
Is this relevant?
2011
2011
e15077 Background: The effects of JI-101 on the pharmacokinetics (PK) of everolimus and vice versa were investigated in an open… (More)
Is this relevant?
2011